Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Longitudinal protection following natural SARS-CoV-2 infection and early vaccine responses: insights from a cohort of community based dental health care professionals

View ORCID ProfileAdrian M. Shields, Sian E. Faustini, Caroline A. Kristunas, Alex M. Cook, Claire Backhouse, Lynsey Dunbar, Daniel Ebanks, Beena Emmanuel, Eddie Crouch, Annika Kroeger, Josefine Hirschfeld, Praveen Sharma, Razza Jaffery, Sylwia Nowak, Samantha Gee, Mark T. Drayson, View ORCID ProfileAlex G. Richter, Thomas Dietrich, Iain C. Chapple
doi: https://doi.org/10.1101/2021.02.24.21252368
Adrian M. Shields
1Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrian M. Shields
Sian E. Faustini
1Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline A. Kristunas
2Institute of Clinical Sciences, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex M. Cook
3The Binding Site Group Ltd, 8 Calthorpe Road, Birmingham, B15 1QT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Backhouse
1Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynsey Dunbar
1Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Ebanks
1Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beena Emmanuel
1Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eddie Crouch
4Birmingham Local Dental Committee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annika Kroeger
5Birmingham Community Healthcare Trust, Birmingham, UK
6Department of Oral Surgery, The School of Dentistry, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josefine Hirschfeld
5Birmingham Community Healthcare Trust, Birmingham, UK
7Periodontal Research Group, University of Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Praveen Sharma
5Birmingham Community Healthcare Trust, Birmingham, UK
7Periodontal Research Group, University of Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Razza Jaffery
5Birmingham Community Healthcare Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylwia Nowak
5Birmingham Community Healthcare Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Gee
5Birmingham Community Healthcare Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark T. Drayson
1Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex G. Richter
1Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex G. Richter
  • For correspondence: i.l.c.chapple{at}bham.ac.uk t.dietrich{at}bham.ac.uk a.g.richter{at}bham.ac.uk
Thomas Dietrich
5Birmingham Community Healthcare Trust, Birmingham, UK
6Department of Oral Surgery, The School of Dentistry, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: i.l.c.chapple{at}bham.ac.uk t.dietrich{at}bham.ac.uk a.g.richter{at}bham.ac.uk
Iain C. Chapple
5Birmingham Community Healthcare Trust, Birmingham, UK
7Periodontal Research Group, University of Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: i.l.c.chapple{at}bham.ac.uk t.dietrich{at}bham.ac.uk a.g.richter{at}bham.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The threshold of protection for anti-SARS-CoV-2 spike glycoprotein antibodies and their longevity are not known. Interpretation of serological results in with respect to international reference material can inform this essential question.

Methods 1,507 West Midlands dental care professionals were recruited into this study in June 2020. Baseline seroprevalence of antibodies directed against the SARS-CoV-2 spike glycoprotein was determined and the cohort was followed longitudinally for 6 months until January/February 2021 through the second wave of the COVID-19 pandemic in the United Kingdom, and commencement of vaccination.

Results Baseline seroprevalence was 16.3% in this cohort, compared to estimates in the general population of between 6-7%. Seropositivity was retained in over 70% of participants at 3 and 6-month follow up and conferred a 74% reduced risk of infection. During follow-up, no PCR-proven infections occurred in individuals with a baseline anti-SARS-CoV-2 IgG level greater than 147.6 IU/ml with respect to the World Health Organization international standard 20-136. Post-vaccination, antibody responses were more rapid and of higher magnitude in individuals with who were seropositive at baseline.

Conclusion Natural infection leads to a serological response that remains detectable in over 70% of individuals 6 months after initial sampling and 9 months from the peak of the first wave of the pandemic. This response is associated with protection from future infection. Even if serological responses wane, a single dose of the Pfizer-BioNTech vaccine is associated with an antibody response indicative of immunological memory.

Funding The Association of Clinical Biochemistry and Laboratory Medicine and The Institute for Global Innovation (IGI) of the University of Birmingham.

Competing Interest Statement

MTD reports personal fees from Abingdon Health, outside the submitted work. AMC is an employee of the Binding Site Group. All other authors declare no competing interests.

Funding Statement

The Association of Clinical Biochemistry and Laboratory Medicine and The Institute for Global Innovation (IGI) of the University of Birmingham.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the London - Camden and Kings Cross Research Ethics Committee (reference 20/HRA/1817). All participants provided written informed consent prior to enrolment in the study

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are available for a period of 24 months from publication upon reasonable request. Proposals should be directed to the corresponding authors.

  • Abbreviations

    AGP
    Aerosol generating procedures
    COVID-19
    Coronavirus disease 2019
    DCP
    Dental care professionals
    GDP
    General dental practitioners
    IRM
    International reference material
    NIBSC
    National Institute for Biological Standards and Control
    PCR
    Polymerase chain reaction
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus 2
    WHO
    World Health Organization
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted February 26, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Longitudinal protection following natural SARS-CoV-2 infection and early vaccine responses: insights from a cohort of community based dental health care professionals
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Longitudinal protection following natural SARS-CoV-2 infection and early vaccine responses: insights from a cohort of community based dental health care professionals
    Adrian M. Shields, Sian E. Faustini, Caroline A. Kristunas, Alex M. Cook, Claire Backhouse, Lynsey Dunbar, Daniel Ebanks, Beena Emmanuel, Eddie Crouch, Annika Kroeger, Josefine Hirschfeld, Praveen Sharma, Razza Jaffery, Sylwia Nowak, Samantha Gee, Mark T. Drayson, Alex G. Richter, Thomas Dietrich, Iain C. Chapple
    medRxiv 2021.02.24.21252368; doi: https://doi.org/10.1101/2021.02.24.21252368
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Longitudinal protection following natural SARS-CoV-2 infection and early vaccine responses: insights from a cohort of community based dental health care professionals
    Adrian M. Shields, Sian E. Faustini, Caroline A. Kristunas, Alex M. Cook, Claire Backhouse, Lynsey Dunbar, Daniel Ebanks, Beena Emmanuel, Eddie Crouch, Annika Kroeger, Josefine Hirschfeld, Praveen Sharma, Razza Jaffery, Sylwia Nowak, Samantha Gee, Mark T. Drayson, Alex G. Richter, Thomas Dietrich, Iain C. Chapple
    medRxiv 2021.02.24.21252368; doi: https://doi.org/10.1101/2021.02.24.21252368

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Allergy and Immunology
    Subject Areas
    All Articles
    • Addiction Medicine (434)
    • Allergy and Immunology (760)
    • Anesthesia (222)
    • Cardiovascular Medicine (3316)
    • Dentistry and Oral Medicine (366)
    • Dermatology (282)
    • Emergency Medicine (480)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
    • Epidemiology (13403)
    • Forensic Medicine (19)
    • Gastroenterology (900)
    • Genetic and Genomic Medicine (5182)
    • Geriatric Medicine (483)
    • Health Economics (786)
    • Health Informatics (3286)
    • Health Policy (1146)
    • Health Systems and Quality Improvement (1199)
    • Hematology (432)
    • HIV/AIDS (1024)
    • Infectious Diseases (except HIV/AIDS) (14657)
    • Intensive Care and Critical Care Medicine (917)
    • Medical Education (478)
    • Medical Ethics (128)
    • Nephrology (526)
    • Neurology (4957)
    • Nursing (263)
    • Nutrition (735)
    • Obstetrics and Gynecology (889)
    • Occupational and Environmental Health (797)
    • Oncology (2531)
    • Ophthalmology (730)
    • Orthopedics (284)
    • Otolaryngology (348)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (547)
    • Pediatrics (1308)
    • Pharmacology and Therapeutics (552)
    • Primary Care Research (559)
    • Psychiatry and Clinical Psychology (4225)
    • Public and Global Health (7526)
    • Radiology and Imaging (1717)
    • Rehabilitation Medicine and Physical Therapy (1022)
    • Respiratory Medicine (982)
    • Rheumatology (480)
    • Sexual and Reproductive Health (500)
    • Sports Medicine (425)
    • Surgery (551)
    • Toxicology (73)
    • Transplantation (237)
    • Urology (206)